Establishment of drug adherence guidelines

Title XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by inserting after section 1711 (42 U.S.C. 300u–16) the following: 1712. Establishment of drug adherence guidelines (a) In general The Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs. (b) Contents In establishing the guidelines under subsection (a), the Secretary shall— (1) incorporate artificial intelligence and machine learning technologies; and (2) to the maximum extent practicable, promote the use of generic and biosimilar drugs. (c) Definitions In this section: (1) Medicare part b drug The term Medicare part B drug means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.). (2) Medicare part d drug The term Medicare part D drug means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e)))..